Clinical trial
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital…
NCT00004317 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Recruiting
Key facts
| NCT number | NCT00004317 |
|---|---|
| Title | Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis |
| Official title | Phase IV Randomized Study of Pyrimethamine, Sulfadiazine, and Leucovorin Calcium for Congenital Toxoplasmosis |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | University of Chicago |
| Status | Recruiting |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Toxoplasmosis |
| Intervention type | Drug |
| Interventions | Leucovorin calcium, Pyrimethamine, Spiramycin, Sulfadiazine |
| Enrollment | 600 |
| Start date | Jul 1, 2000 |
| Primary completion | Dec 1, 2030 |
| Completion | Dec 1, 2030 |
| First posted | Oct 19, 1999 |
| Last update posted | May 14, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: